Gedeon Richter Bulgaria Области на експертиза Оригинални проучвания Cariprazine Scientific posters
Научни издания
Оригинални проучвания Проучване и развитие Биотехнологии Грижа за женското здраве
34th European College of Neuropsychopharmacology Congress, 2-5 October 2021
Cariprazine’s efficacy in residual patients with schizophrenia: a post hoc analysis in a chronic patient population
168 kb 10.11.2021г. PDF
Results of a Phase 1 Trial Investigating the Effect of Cariprazine on the Pharmacokinetics of a Combined Oral Contraceptive
372 kb 10.11.2021г. PDF
World Congress of Biological Psychiatry (organized by WFSBP), 28-30 June 2021, virtual Congress
Broad Spectrum Clinical Efficacy of Cariprazine in Schizophrenia
101 kb 10.11.2021г. pptx
A Post-Hoc Analysis of the Safety Profile of Cariprazine and Potential Relevance for Patient Adherence in Schizophrenia
1330 kb 10.11.2021г. pptx
Efficacy of Cariprazine on Cognitive Symptom Domains in Patients with Schizophrenia and Bipolar Depression
146 kb 10.11.2021г. pptx
European Congress of Psychiatry (EPA), 10-13 April 2021, virtual meeting
Safety During Polypharmacy: A Post-hoc Analysis Examining The Safety Profile Of Cariprazine With Other Antipsychotics In The Cross-Titration Phase
191 kb 10.11.2021г. pdf
The effect of cariprazine on patient engagement: Post hoc analysis of a phase 3 study in patients with predominant negative symptoms of schizophrenia
274 kb 10.11.2021г. pdf
Tolerability of Cariprazine in the Early Stage of Schizophrenia: A Pooled, Post-hoc Analysis of 4 Phase II/III Double-blind Placebo-controlled Trials
211 kb 10.11.2021г. pdf
20th WPA World Congress of Psychiatry, 10-13 March 2021, Virtual Congress
Safety of cariprazine in the light of its receptor profile
267 kb 10.11.2021г. pdf
The efficacy of cariprazine in light of its receptor profile
253 kb 10.11.2021г. pdf
EPA Psychiatry Congress, 4-7 July 2020, virtual meeting
Network analysis of acute symptoms of schizophrenia
410 kb 10.11.2021г. pdf
Network analysis of negative symptoms of schizophrenia in acute and in stable patients with persistent, predominantly negative symptoms
365 kb 10.11.2021г. pdf
Cardiac safety with cariprazine treatment
313 kb 10.11.2021г. pdf
The efficacy and safety of cariprazine in schizophrenia patients with insufficient effectiveness of previous antipsychotic therapy: A Latvian observational study
258 kb 10.11.2021г. pdf
Efficacy of cariprazine in the treatment of acute and primary negative symptoms of schizophrenia: posthoc analyses versus risperidone
289 kb 10.11.2021г. pdf